Conclusion
In view of the possible coexistence of scleroderma with MM, it is suggested that all patients with scleroderma should be screened for monoclonal gammopathy and MM regarding their age. Also, future studies should be directed to determine the exact mechanism of these two conditions association and the effect of MM treatment on SSc improvement.